Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Med Sci ; 2010 Dec; 64(12) 564-576
Artículo en Inglés | IMSEAR | ID: sea-145581

RESUMEN

Initially coined in 1989, biomarkers have become a cornerstone of modern cardiovascular medicine. The past decade has borne witness to the rapid transition of cardiac biomarkers from bench to bedside in the management of patients with coronary artery disease. The implementation of cardiac biomarkers has transformed the internists' approach to cardiovascular patients. This article reviews several cardiac biomarkers in the context of diagnosis, prognosis, risk-assessment and management of patients at risk of adverse cardiovascular outcomes. Biomarkers are presented according to their relevant role in the atherosclerotic cascade, a pathologic classification of particular value for internists, as it defines the role of these agents in the pathogenesis of heart disease. Where pertinent, limitations of cardiac biomarkers are discussed, thus allowing the discerning practitioner to remain cognizant of situations that may lead to spurious marker elevation or suppression. The review concludes with highlights on novel avenues of biomarker research that promise an exciting future for these entities.


Asunto(s)
Biomarcadores/metabolismo , Proteína C-Reactiva/metabolismo , Cardiología/educación , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/epidemiología , Enfermedad de la Arteria Coronaria/metabolismo , Manejo de la Enfermedad , Homocisteína/metabolismo , Humanos , Lipoproteína(a)/metabolismo , Lipoproteínas HDL/metabolismo , Lipoproteínas LDL/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Péptido Natriurético Encefálico/metabolismo , Peroxidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA